Latest news
News
PHOENIX trial reaches 1,000‑participant recruitment milestone
NHS Greater Glasgow and Clyde is celebrating a major achievement as a new study using genetic tests …
News
NHS Greater Glasgow and Clyde Note of Clarification
In response to a number of requests for further information, NHS Greater Glasgow and Clyde wishes to…
News
Men in Greater Glasgow and Clyde more likely to go straight to A&E
NHSGGC data reveals men in Greater Glasgow and Clyde are more likely than women to go straight to A&…
Additional news resources
Contacts for media and journalist enquiries only!
News on social media
Facebook Posts
We’re making it easier to find out more about Primary Care.![]()
![]()
Alongside the full strategy, we’ve published an executive summary and an easy read version, with accessible formats and translations available.![]()
![]()
This makes it easier for more people to find out what Primary Care is and how it supports you and your community.![]()
![]()
Find out more via our Primary Care hub by using the QR code or visiting 👉 www.nhsggc.scot/primarycare
A new heart failure treatment could allow patients to return home days earlier than expected, a UK-wide trial has found. ![]()
![]()
The SUBCUT HF II trial, led by the University of Glasgow and co-sponsored by NHS Greater Glasgow and Clyde, has shown that a wearable mini‑pump and innovative medication can safely help patients continue treatment at home.![]()
![]()
This pioneering approach required new ways of safely managing both the medicine and the device, supported by our Research and Innovation Pharmacy teams.![]()
![]()
Find out more about this trial here: www.nhsggc.scot/innovative-heart-failure-treatment-proves-transformative-for-patients/
Was this helpful?
Thanks for your feedback!